Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 1.14B 1.01B 952M 863M 1.62B 109B 1.63B 11.42B 4.4B 55.85B 4.28B 4.19B 180B P/E 2026 *
-24.9x
P/E 2027 * -32.2x
Enterprise Value 1.23B 1.09B 1.03B 934M 1.75B 118B 1.77B 12.35B 4.76B 60.43B 4.63B 4.53B 194B EV / Sales 2026 *
5.83x
EV / Sales 2027 * 5.32x
Free-Float
45.46%
Yield 2026 *
-
Yield 2027 * -
1 day+0.26%
1 week+2.55%
Current month+0.13%
1 month-0.39%
3 months+19.72%
6 months+167.48%
Current year+135.38%
1 week 7.24
Extreme 7.245
7.76
1 month 6.48
Extreme 6.485
7.76
Current year 2.8
Extreme 2.8
9.42
1 year 2.54
Extreme 2.545
9.42
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
46.43
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 08/06/2025
Director of Finance/CFO 59 30/06/2025
Chief Operating Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 50 01/03/2016
Director/Board Member 65 01/11/2020
Director/Board Member 61 01/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Tax

Chief Executive Officer

-29,250 0.0196%
31/08/26 Tax

Chief Financial Officer

-5,465 0.0037%
10/08/26 Tax

Chief Executive Officer

-29,250 0.0198%
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%+2.55%+170.32%-23.50% 1.14B
+31.48%+35.81%+547.98%+217.58% 6.55B
+0.91%+2.53%+113.74%+427.89% 4.59B
+1.88%+6.27%+37.10%+106.36% 3.7B
-0.90%+13.33%+330.82%+814.57% 3.31B
-0.99%+0.80%-8.74%-15.35% 2.53B
-1.67%-3.25%+50.19% - 1.71B
-1.75%-1.46%+35.34%+57.85% 1.13B
+6.56%+13.56%-17.54%+143.91% 680M
-0.89%-0.77%-30.73%-24.43% 527M
Average +0.53%+7.18%+122.85%+189.43% 2.59B
Weighted average by Cap. +0.68%+12.62%+216.94%+271.78%

Financials

2026 *2027 *
Net sales 212M 187M 177M 160M 301M 20.32B 304M 2.12B 818M 10.38B 795M 778M 33.39B 225M 198M 188M 170M 319M 21.56B 322M 2.25B 867M 11.01B 844M 825M 35.42B
Net income -53.45M -47.17M -44.63M -40.47M -75.88M -5.13B -76.63M -535M -206M -2.62B -201M -196M -8.43B -38.2M -33.71M -31.89M -28.92M -54.23M -3.67B -54.76M -383M -147M -1.87B -143M -140M -6.02B
Net Debt 93.41M 82.44M 78M 70.74M 133M 8.96B 134M 936M 361M 4.58B 351M 343M 14.73B 58.85M 51.94M 49.14M 44.57M 83.56M 5.65B 84.38M 590M 227M 2.88B 221M 216M 9.28B
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
29/09/26 $7.650 +0.26% 1,755,486
28/09/26 $7.630 +0.39% 1,942,349
25/09/26 $7.600 -0.65% 1,930,865
24/09/26 $7.650 +3.80% 2,392,705
23/09/26 $7.370 -1.21% 1,549,775
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
7.650USD
Average target price
7.600USD
Spread / Average Target
-0.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock